- CLINICAL TRIALS
- PARTNERS
- …
- CLINICAL TRIALS
- PARTNERS
- CLINICAL TRIALS
- PARTNERS
- …
- CLINICAL TRIALS
- PARTNERS
Health Systems
Supporting personalised healthcare on site and at home.
We partner with health systems to offer AmDTx to patients and employees, with the goal of improving both mental health and human performance.
Our partnerships with health systems provide physicians with a means to personalise therapy for their patients. A major benefit of AmDTx in the healthcare setting is the speed of deployment. Individuals worldwide face long wait times for mental health services (OECD Waiting Times for Health Services, 2020). AmDTx adapts to the needs of every patient and provides objective wellbeing insights obtained between healthcare visits that physicians can leverage for treatment decisions.
Patient Testimonials
"…I can accept negative thoughts better than before and I can practice meditation to calm me down if the day was really stressful. I found that when I practice meditation before I sleep, I can sleep better than before, and I don't wake up randomly in the middle of the night…"
"…I learned to unwind and be more aware of my surroundings. After a stressful day, I looked forward to doing the meditation for at least 10 minutes and it helped me become stress-free and understanding of what is there around me..."
"…I felt more calm and relaxed immediately after my 10 minute sessions. I am now able to pay more attention to my body and spot tense areas. The app also improved my focus on everyday tasks without getting distracted by other external things…"
What we offer
✓ Clinical resilience training at scale
✓ Intervention development
✓ Full backend integration enabling clinicians to leverage AmDTx data in clinical decision making
✓ Remote patient monitoringInterventions
Scale clinical practices through digital integration within AmDTx.
Licensing
Personalise treatment regimens with objective quantification of wellbeing.
Clinical Trials
Deliver the latest in digital mental healthcare to patients.
Certifications
Mobio Interactive’s digital therapeutic platform “AmDTx” is DCB 0129 and ISO 27001 certified; GDPR-, HIPAA- and PHIPA-compliant; and undergoing certification for CE MDR Class IIa, ISO 13485, ISO 9000 and ISO 82304-2.
Validating the accuracy of our digital biomarkers and the efficacy of our digital theragnostic platform, AmDTx, Mobio has published 19 peer-reviewed papers to date from 17 completed clinical studies.
Effective and accessible healthcare for every human.